Vir Biotechnology, Inc. (VIR)
9.96
-0.51
(-4.87%)
USD |
NASDAQ |
Oct 16, 16:00
9.80
-0.16
(-1.61%)
After-Hours: 20:00
Vir Biotechnology Net Income (TTM) : -251.68M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -251.68M |
| March 31, 2026 | -442.72M |
| December 31, 2025 | -437.99M |
| September 30, 2025 | -499.65M |
| June 30, 2025 | -550.23M |
| March 31, 2025 | -577.65M |
| December 31, 2024 | -521.96M |
| September 30, 2024 | -533.34M |
| June 30, 2024 | -483.04M |
| March 31, 2024 | -539.44M |
| December 31, 2023 | -615.12M |
| September 30, 2023 | -600.75M |
| June 30, 2023 | -262.02M |
| March 31, 2023 | -143.74M |
| December 31, 2022 | 515.84M |
| Date | Value |
|---|---|
| September 30, 2022 | 1.143B |
| June 30, 2022 | 1.078B |
| March 31, 2022 | 1.216B |
| December 31, 2021 | 528.58M |
| September 30, 2021 | -102.32M |
| June 30, 2021 | -297.36M |
| March 31, 2021 | -390.34M |
| December 31, 2020 | -298.66M |
| September 30, 2020 | -256.79M |
| June 30, 2020 | -220.49M |
| March 31, 2020 | -223.25M |
| December 31, 2019 | -174.68M |
| September 30, 2019 | -137.30M |
| June 30, 2019 | -122.45M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Moderna, Inc. | -3.151B |
| Vaxcyte, Inc. | -1.064B |
| Caribou Biosciences, Inc. | -103.40M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |